Hudson Bay Capital Management LP Exelixis, Inc. Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $1.21 Million - $1.44 Million	-60,000 Reduced 52.17%	55,000 $1.31 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $96,250 - $120,650	-5,000 Reduced 4.17%	115,000 $2.76 Million
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $190,400 - $227,399	-10,000 Reduced 7.69%	120,000 $2.62 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $272,550 - $307,200	-15,000 Reduced 10.34%	130,000 $2.48 Million
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $978,000 - $1.16 Million	-60,000 Reduced 29.27%	145,000 $2.81 Million
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $1.12 Million - $1.3 Million	75,000 Added 57.69%	205,000 $3.29 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $470,400 - $668,100	30,000 Added 30.0%	130,000 $2.04 Million
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $1.87 Million - $2.49 Million	-110,000 Reduced 52.38%	100,000 $2.27 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $712,800 - $984,600	45,000 Added 27.27%	210,000 $3.84 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $163,000 - $211,400	-10,000 Reduced 5.71%	165,000 $3.49 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $2.06 Million - $2.94 Million	115,000 Added 191.67%	175,000 $3.19 Million
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $615,900 - $756,600	-30,000 Reduced 33.33%	60,000 $1.36 Million
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $551,700 - $744,000	30,000 Added 50.0%	90,000 $1.81 Million
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $433,800 - $654,000	-30,000 Reduced 33.33%	60,000 $1.03 Million
Q4 2019 Feb 12, 2020	BUY	$15.15 - $18.89 $1.36 Million - $1.7 Million	90,000 New	90,000 $1.59 Million
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $2.74 Million - $3.47 Million	-140,000 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$13.65 - $21.8 $887,250 - $1.42 Million	-65,000 Reduced 31.71%	140,000 $2.75 Million
Q2 2018 Aug 13, 2018	BUY	$18.56 - $22.45 $3.25 Million - $3.93 Million	175,000 Added 583.33%	205,000 $4.41 Million
Q1 2018 May 14, 2018	BUY	$22.15 - $31.89 $664,500 - $956,700	30,000 New	30,000 $665,000

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.14 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$995 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$862 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$521 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$388 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account